Wistar Institute Researchers Discover New Combination Therapy Approach for Metastatic Ovarian Cancer
November 22, 2024
November 22, 2024
PHILADELPHIA, Pennsylvania, Nov. 22 (TNSres) -- The Wistar Institute issued the following news release:
* * *
Zhang Lab Demonstrates Novel Combination of Beta Glucan and Interferon Gamma Results in Tumor Regression
* * *
The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and lab have discovered a new approach to treating ovarian cancer . . .
* * *
Zhang Lab Demonstrates Novel Combination of Beta Glucan and Interferon Gamma Results in Tumor Regression
* * *
The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and lab have discovered a new approach to treating ovarian cancer . . .